Journals / Erciyes Tıp Dergisi / 2012 / Cilt: 34 - Sayı: 2

Deneysel kontrollü non-heart beating donör modelinde met-rantes’in karaciğer hasarını önleyici etkisi

The effect of met-rantes on liver damage in a controlled experimental non-heart beating donor model

Pages
69–72
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: AST and ALT levels were significantly lower in the Met-RANTES group (P

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study was to investigate the effect of Met–RANTES on the viability of hepatocytes in an experimental controlled non-heart beating donor models in rats, and also to determine the usefulness of these grafts.
📊
Key Findings & Data:Material and Method: Thirty Wistar-Albino rats weighing between 225 and 290 g were used in this study, and were divided into two groups (study and control) of 10 rats each.
💡
Conclusion & Impact:Results: AST and ALT levels were significantly lower in the Met-RANTES group (P
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study was to investigate the effect of Met–RANTES on the viability of hepatocytes in an experimental controlled non-heart beating donor models in rats, and also to determine the usefulness of these grafts. Material and Method: Thirty Wistar-Albino rats weighing between 225 and 290 g were used in this study, and were divided into two groups (study and control) of 10 rats each. Cardiac arrest was performed by intracardiac KCl injection (0.2 mL). The interval between the cessation of cardiac activity and organ retrieval was 30 minutes. Before the cessation of cardiac activity, 0.1 mL heparin was administered subcutaneously to each rat. 0.05 mL saline was given to the control group and 1 g/kg Met-RANTES was given to the study group 2 hours before cardiac arrest. Subsequently, a suitable catheter (3.5 French) was inserted into the portal vein. Liver grafts were washed out with 50 mL Euro Collins solution via the portal vein catheter. Liver grafts, which were dissected totally, were reperfused for 60 minutes with HTK solution using a circulator system. AST and ALT levels were measured in the perfusion fluid. Results: AST and ALT levels were significantly lower in the Met-RANTES group (P

Özet

Amaç: Sıçanlarda deneysel kontrollü non–heart beating donör modelinde, met-RANTES’in karaciğer hücre canlılığına etkisini ve bu tür greftlerin kullanılabilirliğini araştırmak. Gereç ve Yöntem: Çalışmada ağırlığı 225-290 gram arasında değişen, 30 adet Wistar-Albino erkek sıçan kullanıldı. Her biri 10 sıçandan oluşan kontrol ve çalışma grupları oluşturuldu. Kardiyak arrestten önce tüm sıçanlara 0,1 mL heparin subkutan olarak uygulandı. Kontrol grubundaki deneklere kardiyak arrestten 2 saat önce 0,5 mL SF ve çalışma grubundakilere 1 μg/kg met-RANTES intraperitoneal yolla verildi. Sıçanlara 0,2 mL intrakardiyak KCL verilerek kardiyak arrest sağlandı. Tüm gruplarda 30 dakika beklendikten sonra orta hat insizyonla laparotomi yapıldı. Tüm gruplardaki deneklere total hepatektomi uygulandı. Yukarıda vena kava ve alt tarafta vena porta disseke edilerek serbestleştirildi. Daha sonra lumenine uygun (3,5 french) bir kateter yardımıyla portal ven kateterize edildi. Bu kateter yardı- mıyla 50 mL Euro Collins solüsyonu ile invivo olarak karaciğer yıkandı. Total olarak çıkarılan karaciğerler sirkulatuar bir sistem yardımıyla HTK solüsyonu ile 60 dk perfüze edildi. AST ve ALT ölçümleri için perfüzyon sıvıları uygun koşullarda saklandı. Bulgular: AST ve ALT değerleri, met-RANTES verilen grupta istatistiksel olarak anlamlı ölçüde düşük bulundu (p

🔖

Cite This Article

ARTIŞ, T., AKALIN, B., YILMAZ, Z. (2022). Deneysel kontrollü non-heart beating donör modelinde met-rantes’in karaciğer hasarını önleyici etkisi. Erciyes Tıp Dergisi, Cilt: 34 - Sayı: 2, 69–72. https://ajindex.com/articles/502475

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Schwartz SI. Liver. In: Brunicardi FC, Andersen DK, Timothy R, Dunn DL, Hunter JG, Pollock RE (eds), Schwartz’s Principles of Surgery (8th ed) McGraw-Hill, Philadelphia 2004,pp.1395-435
  2. Kimber RM, Metcalfe MS, White SA, Nicholson ML. Use of non-heart- beating donors in renal transplantation. Postgrad Med J 2001; 77(913): 681-5. [CrossRef] 3. Appay V, Rowland-Jones SL. RANTES: a versatile and controversial chemokine. Trends Immunol 2001; 22(2): 83-7. [CrossRef] 4. Elsner J, Petering H, Hochstetter R, Kimmig D, Wells TN, Kapp A, et al. The CC Chemokine antagonist Met-RANTES inhibits eosinophil effec- tor functions through the chemokine receptors CCR 1 and CCR. Eur J Immunol 1997; 27(11): 2892-98. [CrossRef] 5. Gomez del Moral M, Aviles B, Colberger IK, Campos-Martin Y, Suela J, Alvarez J, et al. Expression of adhesion molecules and RANTES in kid- ney transplant from non heart-beating donors. Transpl Int 2005; 18(3): 333-40. [CrossRef] 6. Gröne HJ, Weber C, Weber KS, Gröne EF Rabelink T, Klier CM, et al. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment. FASEB 1999; 13(11): 1371-83
  3. Reich DJ, Munoz SJ, Rothstein KD, Nathan HM, Edwards JM, Hasz RD, et al. Controlled non heart-beating donor liver transplantation: a successful single center experience, with topic update. Transplantation 2000; 70(8): 1159-66. [CrossRef] 8. Lopez-Navidad A, Caballero F Extended criteria for organ acceptance. Strategies for achieving organ safety and for increasing organ pool. Clin Transplant 2003; 17(4): 308-24. [CrossRef] 9. Manzarbeitia CY, Ortiz JA, Jeon H, Rothstein KD, Martinez O, Araya VR, et al. Long-term outcome of controlled, non-heart-beating donor liver transplantation. Transplantation 2004; 78(2): 211-5. [CrossRef] 10. Delva E, Camus Y, Nordlinger B, Hannoun L, Parc R, Deriaz H, et al. Vascular occlusions for liver resections. Ann Surg 1989; 209(2): 211-8. [CrossRef] 11. Huguet C, Gavelli A, Chieco A, Bona S, Harb J, Joseph JM, et al. Liv- er ischemia for hepatic resection: where is the limit. Surgery 1992; 111(3): 251-9
  4. Bessems M, Doorschodt BM, Albers PS, et al. Wash-out of the non- heart-beating donor liver: a comparison between ringer lactate, HTK, and polysol. Transplant Proc 2005; 37(1): 395-8. [CrossRef] 13. D’alessandro AM, Hoffmann RM, Knechtle SJ, Odorico JS, Becker YT, Musat A, et al. Liver transplantation from controlled non-heart-beating donors. Surgery 2000; 128(